Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oxford Nanopore TechnologiesOXFYY -0.50%50 Cash Ratio is 2.16 as of Dec. 2025, which is 29% below its 10-year median of 3.03. GuruFocus rates OXFYY with a GF Score™ of 50/100 and a GF Value™ of $10.29 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,384 Biotechnology companies, Oxford Nanopore Technologies ranks worse than 57.8% on this metric.
Oxford Nanopore Technologies has a Cash Ratio of 2.16. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Oxford Nanopore Technologies's Cash Ratio or its related term are showing as below:
OXFYY'
s Cash Ratio Range Over the Past 10 Years
Min: 0.36 Med: 3.03 Max: 5.89
Current: 2.16
During the past 8 years, Oxford Nanopore Technologies's highest Cash Ratio was 5.89. The lowest was 0.36. And the median was 3.03.
OXFYY's Cash Ratio is ranked worse than 57.8% of 1384
companies
in the Biotechnology industry
Industry Median: 2.94
vs OXFYY: 2.16
Oxford Nanopore Technologies (OTCPK:OXFYY) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Oxford Nanopore Technologies Cash Ratio Related Terms
Oxford Nanopore Technologies Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Oxford Nanopore Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies Cash Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Nanopore Technologies (OXFYY) has a Cash Ratio of 2.16 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Oxford Nanopore Technologies and its competitors. This is 29% below median its historical median of 3.03. Over the past decade, Oxford Nanopore Technologies' Cash Ratio has ranged from 0.36 to 5.89. According to the industry distribution chart, Oxford Nanopore Technologies ranks #800 out of 1384 companies in the Biotechnology industry, placing it in the top 57.8%.
Is Oxford Nanopore Technologies' Cash Ratio too high?
Oxford Nanopore Technologies' current Cash Ratio of 2.16 is 29% below median its 10-year median of 3.03. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 5.89. The Biotechnology industry median Cash Ratio is 2.94. Oxford Nanopore Technologies' value of 2.16 is 26.5% below this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #800 out of 1384 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Cash Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #800 out of 1384 companies for Cash Ratio. This places Oxford Nanopore Technologies in the lower half of its industry. The industry median Cash Ratio is 2.94. Oxford Nanopore Technologies' value of 2.16 is 26.5% below this benchmark. Historically, Oxford Nanopore Technologies' own Cash Ratio has ranged from 0.36 to 5.89 over the past decade. While the company's 10-year median is 3.03 vs. the industry median of 2.94, Oxford Nanopore Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Biotechnology company?
The median Cash Ratio among Biotechnology companies is 2.94, based on 1,384 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current Cash Ratio of 2.16 is 26.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median Cash Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current Cash Ratio is 2.16, which is 29% below median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $10.29, compared to a current price of $5.97 — trading 42% below its estimated fair value. The current Cash Ratio is 2.16, which is 29% below median its 10-year median of 3.03 and 26.5% below the Biotechnology industry median of 2.94. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current Cash Ratio is 2.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued.
The current stock price of $5.97 is trading 42% below its estimated GF Value™ of $10.29.
GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.
Key valuation signals for OXFYY:
Cash Ratio: 2.16 (29% below median its 10-year median of 3.03)
GF Value™: $10.29 vs. price of $5.97 (42% below fair value)
Industry Position: 26.5% below the Biotechnology median (#800 of 1384)
No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score
Get the complete analysis for OXFYY
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OXFYY has been successfully added to your 
